Member Info for Rambo23

Another Big buy of 235k at 66.79787 traded at 12.34....hummm

142k share buy popped up at 4.38!

Bamb re your funding comment. He can't win either way can he. Shareholders wanted the funding question put to him he has answered it clearly on a video and the recent RNS have also stated the position on this. Additionally it has been highlighted on here that there is NO current headroom to do a placing currently (at least until the AGM re-votes on this aspect as they do each year as standard procedure also referenced in yesterdays video.) The new acquisition doesn't require external funding as per the RNS comms and we have £5.6m in warrants that once the SP is north of 3p will come into play. On top of that the house broker isn't contacting clients on this. Lastly we are accruing revenue on the AUM we have. I'm not concerned.

Some good movement yesterday up 9%. Looked like the majority of the volume were buys out of the 2.2m traded. A few more days like that please.

Daisy try reading the RNS it’s all there in black and white….

Rand and to add to that list Mark has circa 50m warrants as he took part in the placing. The warrants are exercisable at 3p which would bring in £1.5m cash into the company on his warrants alone. A solid investment and he isn't messing around.

Well said Rand, it isn't rocket science is it. The Business Model is to grow AUM and collect the revenue from it and like you say we were at 2p when AUM was 20m..... Crazy.

Daisy your awareness or lack of is part of the problem I don't mean to sound harsh but it's true and I will explain why. I'm afraid you are deluded if you think constant whinging and negative comments day after day week after week planting seeds of doubt whether right or wrong doesn't have a negative influence on some people and therefore the SP especially over the longer term to sell, not buy anymore shares or put off a new investor. Positive comments are have the opposite effect. As you are a shareholder only positive news from the company, positive comments and investor buying will benefit your investment correct? Therefore negative news, no news from the company or negative comments and sales from people will damage your investment. Therefore be aware of your negative influence (I can't say positive as I can't recall the last time you said anything positive without looking) and learn to vocalise less negative comments or ongoing frustrations which might influence shareholders to sell or doubt their investment. Fair enough discuss something in a constructive manner which might not be so positive but repeating the same things isn't helping anyone. We are all aware news is overdue and I'm sure we will be told when the time is appropriate as per the last paragraph of the recent RNS.

Given the low liquidity of this share we know small volumes impact the price up or down significantly which can lead to panic or fear on the sale of a few 100k shares which is a complete waste of energy trying to rationalise why the sale has happened. It is also worth remembering the SP rarely reflects the underlying value of a business and in my view where were are now is way off the mark. I expect the SP to move higher on any positive news from the Company throughout 2022 so lets get behind the positive news we have had and not bad news we haven't had.

Daisy we all had the chance to sell at 8p and make several 100% or at least very decent profits so take some personal responsibility will you. The facts are your incessant negativity will never aid the share price only hinder it so you might want to consider that if you still have shares.

Well stated Bobby that is all fair and the reality of what has happened. I will enjoy reading that again as I appreciate other peoples constructive views here. I loved the Little Dave points. Bluepanther I think the lack of comms has been raised by several shareholders recently and I expect we will see this improve.

Candi I will answer your question and I'm not afraid to do so. 'Whatever happened to the RCF? Whatever happened to the investment into the fund by the asset manager'. Simply we don't yet know the current status only the guidance from the Q2 update which was positive. Things don't always happen when you want them too. Given the prospect of such a large investment/ facility nothing happens until every piece of due diligence is completed and then all the pen pushers and risk committees need to agree if and when to move forward. Anyone who has worked in Investment Banking or Insurance will know just how difficult it is to get anything signed off due to the politics and getting people to put their names to things. Given the Northstar acquisition last year if I were the RCF counterparty I wouldn't complete any deal until the DD was completed on the largest deal Alpha had ever done and was given a clean bill of health by the auditors and FCA approval obtained (prospectus) to the Northstar deal and it is squeaky clean. They simply wouldn't take the reputational risk with such a large investment in a small company without all those things happening. Clearly the scope RCF/ Direct Investment has changed over time and with that brings other complexities as per the RNS guidance. Perhaps the long drawn out process of getting that FCA approval last year has had an impact who knows. Given the details Bobby has listed and the points I have raised previously to you the fact we have over $350 AUM is significant and very positive vs where we were Jan 2020 at $10m. Now given last year we added approx 300m AUM from other sources it clearly shows that we are not reliant on the RCF/ direct investment are we. Perhaps it was the focus 2 years ago but the world doesn't stop spinning so if it happens great if not we move on and get AUM elsewhere.

In the interests of transparency and moving forward please can you answer the following questions.

1. Do you acknowledge the business has grown AUM from circa $10m in Jan 2020 to circa $350m in Dec 2021? Yes/ No
2. Do you agree the business model is about increasing AUM wherever it comes from and the fee revenue it generates? Yes/ No
3. Why do you have such a problem with GS and the company? It appears personal
4. What efforts have you made to contact GS to discuss your investment assuming you have one and your concerns?
5. How many shares do you have and at what average price?
6. If you are so negative about this company and its prospects why don't you sell up and stop poisoning the board with constant negativity which helps no one?
7. Do you think GS will deliver more AUM this year?

Candi I answered your question about SP direction quite clearly. This has been addressed many times before by others so your statement 'who can't seem to ever explain why the SP goes down' is factually incorrect and inaccurate.

As for your second point I have explained the business model which is to increase AUM and fee revenue is it not? I don't care where it comes from as long as it grows. I like the fact we aren't dependent on one strategy and are flexible to come up with solutions to move forward and as a result the business is growing is it not? You are too hung up on those aspects which may or may not happen in the future and fail to acknowledge the business has been growing in front of you whilst you have been moaning. Look at where things were Jan 2021 and where they were in July 2021. How much did the AUM increase in that time? You can't bring yourself to mention anything positive at all which means you either have an agenda or you really don't understand this business model. You fail to answer simple questions put to you time and again. The BOAGF AUM has now doubled and we await further details on the insurance business. At least I can provide a balanced and realistic point of view, yours is all negative.

As for the policing everyone has a right to report a post if they so choose, so if your posts vanish take notice. It means people on this board value your contribution as zero, reject you, think you don't add any value and in the bin you go.

Candi more inaccurate waffle from you as per usual. The SP going down recently is fairly simple let me explain it. More sellers than buyers...who would have guessed it! Everyone knows the lack of news flow has been a factor here and the other one is low liquidity which means large movements in the SP on low volumes. That doesn't mean the business has been doing nothing since last July and the Q2 update though does it? A doubling in the AUM of the BOAGF is the latest confirmation of that. As for the business model as I explained before it is all about increasing AUM which will generate fee revenue. There are a variety of ways to achieve this and personally as long as both are growing then we are moving forward. I still can't understand your contempt for this Company and or GS and the time you waste here, it isn't normal. Seems personal to me and pathetic.

Ophidian on the Dose escalation RNS timings wouldn't it make sense to tell the market post this actually happening rather than before any patients have been dosed. This would give confidence that nothing bad has happened to any patients as some would have already been dosed. Bit risky telling that market in advance of dosing in my view. Just tell us what has happened and things are ok. Perhaps that is why we haven't had an RNS on this although we were expecting one in Q4. Alternatively delays as you mention could play a role.

On another note by the very fact that AVA3996 has been chosen as the second precision pro drug, do you have any view on what costs would have been incurred on this drug preparation to get us to a point where they could make this selection and secondly specifically what new costs and when would they be incurred based on the now confirmed AVA3996 selection ie immediately or all down the line?. My assumption is the AVA3996 is now racking up further costs since its selection and is therefore not a smoke and mirrors situation ie we have chosen this second drug but have no financial downside yet as committed spending hasn't yet occurred? I would prefer committed spending has occurred since the selection as it then demonstrates this is a real financial commitment by the company if that makes sense and further proves AVA6000 might be going well otherwise why bother with AVA3996 progressing. Thanks

Daisy I don't think you understand the objective of the business here. Simply put it has always been to build AUM and earn revenues from that whilst keeping a low cost base.

In Jan 2021 we had circa 20m AUM which then went to over 300m AUM on the Northstar deal. Today in 2022 we have confirmation the BOAGF has doubled AUM in the last year alone. What we don't yet know is the current total AUM across the group which I'm sure will be confirmed at some point but it's not unreasonable to assume this has increased since the last update on this. All of this contributes to an ever increasing revenue stream aligned to the business model and meets the primary objective stated above. It may not be happening as fast as some people want but thats their issue the fact is the AUM is growing.

You can talk down the Northstar deal but I bet you weren't unhappy with the 8p share price following that deal were you. What you are unhappy with is you didn't sell then. The Northstar deal instantly created another revenue stream for the business and instead of acknowledging the benefits of this you would prefer to speculate a rationale which is negative to justify its existence which is pathetic even though it fulfills the primary objective please read line one again above. In business you don't win every pitch or deal for so many different reasons. You are moaning about the past rather than what's is in front of you today. You are hung up on deals yet to materialise and completly **** off the ones that have been converted and provided material change to the business and yet you are still a shareholder? The benefit of having fingers in different pies is you are not putting all your eggs in one basket and managing your risk. The reality is the last 2 years it simply hasn't been business as usual but now things are getting back to a normality I expect things to improve.

Pello getting investigated by the FCA was bad luck and very bad timing and had nothing to do with ALGWs performance or GS and you know that. You point out the SP went up 13% and down again thats because of low volume and some sales yet you fail to grasp this simple concept which is a reality in low liquidity shares. As for the prospectus you only have to look at other companies which have also gone through this process and taken 6 months + to get sign off from the FCA, some are still waiting for this.

Communication to shareholders certainly needs to improve and be as regular as possible. I hope that with Arden onboard there will be more support to engage current and new shareholders, they have a large II client base so that may well pay dividends in the future. Personally I see my investment here has further de-risked in the last year and the potential for future growth is significant. I'm agnostic as to how, where and when AUM is added across the strategies as long as it continues to grow.

Meeten its quite simple there has hardly been any volume and approx 1.5m has been sold today which is why we are down. We know the SP is sensitive to changes especially with little volume. Goodbye to the seller an opportunity for people to buy cheap shares if they choose to. Todays RNS was clearly a BOAGF update and not an update on the wider business.

Daisy why don't you just sell up and enjoy the rest of your life its very easy for you to do that and would be doing us all a favour. Your constant moaning and negativity do nothing for anyone. In fact you add zero value to the discussions for genuine shareholders and you post inaccurate rubbish. How can you say 'there has been talk of progress and contracts for over four years.Nothing has materialized'. That is completely wrong the AUM growth in the fund provided today is in black and white covering a multi year period, you fail to mention the acquisition of Northstar which came out of nowhere. There are positives in the RNS today but you cannot even bring yourself to highlight any of that so why are you here I don't understand? What a sad life you lead.

SBP / Goldenball the key point to remember here is we generate management fees on the AUM. GS has always said he wants sticky revenues streams to come from long term investments into the business. He is focused on building AUM through the various strategies to achieve this which is the business model focused on UHNWIs and Corporates

We are also due news on AVA3996 progress to clinical development. Unclear why we didn't see an update on this before the end of 2021 as AS seemed very positive on this in recent interviews. Detail below from 30th Sept interims as a reminder.

The next most advanced pre|CISION™ pro-drug is AVA3996, a FAP-activated analogue of Velcade, Takeda's proteasome inhibitor which comes off patent in 2022. The global proteasome inhibitors market size is expected to be worth $1.7 billion by 2023 (source) and Velcade represents just over half of that market. As with all chemotherapies the benefit of these drugs is limited by toxicities and tolerability for patients. In the case of Velcade, there are significant side effects such as peripheral neuropathy which has limited its approval, principally to multiple myeloma. A potentially safer proteasome inhibitor, such as AVA3996, could win significant market share for the treatment of multiple myeloma and also be used to treat solid tumours, such as pancreatic cancer. Pancreatic cancer also exhibits the highest level of FAP activity of any solid tumour and therefore a FAP activated pro-drug could have significant potential in this area of high unmet need.

Excellent progress has been made in the AVA3996 programme which remains on track for clinical development candidate selection by the end of 2021. A number of in-vivo studies aimed at de-risking the pre-clinical and clinical development of AVA3996 have been completed. A contract manufacturing organisation for the drug substance and drug product has been identified and the Company is investigating potential fast-track approval options.

I'm not so sure Daisy. I could only get 3.06 for 200k and 3p for 400k at a similar time.

Worth noting and looking at the ABDX RNS today...the CEO and non Ex Chairman have put £500k into the oversubscribed 25p placing between them.

V2 - Well said! The shares in issue are 432m today and tomorrow will be the same. Anyone who bothers to read the prospectus it clearly states the shares in issue before the deal were 240,815,959 (see page 7) add 187m (placing shares from start of year) and you get to 427m plus the additional shares exercised since gets you to 432m!